Promoting angiogenesis with mesoporous microcarriers through a synergistic action of delivered silicon ion and VEGF
Prof. Kim HW granted NRF fund (300M won ~300,000$) per year up to 5 years for the research on immune- or angio-modulatory biomaterials.
A new type of cement (named 'nanocement') formulated with bioactive glass nanoparticles showed potential performance including angiogenic stimulation and osteoinductivity. The work was published in Biomaterials, 2018, 162, 183, by Kang MS et al.
A collaborative commercialization research institute, named GENTREN (GENoss + itREN) established with the supportive fund (500M/y up to 2 years) from NRF.
Gentren started to develop and commercialize dental synthetic bone graft materials and other root canal filling materials.
Our research and technologies initiated to become reality to the market throughout this project.
This was motivated by the transfer of two intellectural properties of Prof. Kim HW to biomaterials company (Genoss) with 100M won and 3% royalty
Bioactive multi-functional nanoparticles developed to treat and repair infected pulpal tissue through the delivery of silver ion and antibiotics. This work was published in Biomaterials, 2017, 142, 62 (Drug/ion co-delivery multi-functional nanocarrier to regenerate infected tissue defect).
Prof. Lee HH developed glass ionomer cement with improved mechanical properties and mineralization with the help of bioactive nanoparticles, highlighting the potential for dental caries treatment. This work was published in Dental Mater, 2017, 33(7), 805-817